For help on how to get the results you want, see our search tips.
1496 results
Medicine
Shortages Remove Shortages filter
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Silodyx (updated)
silodosin, Prostatic Hyperplasia
Date of authorisation: 29/01/2010, Revision: 13, Authorised, Last updated: 22/11/2019 -
List item
Human medicine European public assessment report (EPAR): Trevicta (previously Paliperidone Janssen) (updated)
paliperidone palmitate, Schizophrenia
Date of authorisation: 05/12/2014, Revision: 9, Authorised, Last updated: 22/11/2019 -
List item
Human medicine European public assessment report (EPAR): Inlyta (updated)
axitinib, Carcinoma, Renal Cell
Date of authorisation: 03/09/2012, Revision: 12, Authorised, Last updated: 22/11/2019 -
List item
Human medicine European public assessment report (EPAR): Instanyl (updated)
Fentanyl citrate, Pain, Cancer
Date of authorisation: 20/07/2009, Revision: 22, Authorised, Last updated: 21/11/2019 -
List item
Human medicine European public assessment report (EPAR): Edistride (updated)
dapagliflozin propanediol monohydrate, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
Date of authorisation: 09/11/2015, Revision: 11, Authorised, Last updated: 21/11/2019 -
List item
Human medicine European public assessment report (EPAR): Erelzi (updated)
etanercept, Arthritis, Psoriatic, Psoriasis, Arthritis, Juvenile Rheumatoid, Arthritis, Rheumatoid, Spondylitis, Ankylosing
Date of authorisation: 23/06/2017,
, 
, Revision: 5, Authorised, Last updated: 21/11/2019
-
List item
Human medicine European public assessment report (EPAR): Fulphila (updated)
pegfilgrastim, Neutropenia
Date of authorisation: 20/11/2018,, , Revision: 2, Authorised, Last updated: 21/11/2019
-
List item
Human medicine European public assessment report (EPAR): Otezla (updated)
apremilast, Arthritis, Psoriatic, Psoriasis
Date of authorisation: 15/01/2015, Revision: 11, Authorised, Last updated: 21/11/2019 -
List item
Human medicine European public assessment report (EPAR): NovoSeven (updated)
eptacog alfa (activated), Hemophilia B, Thrombasthenia, Factor VII Deficiency, Hemophilia A
Date of authorisation: 23/02/1996, Revision: 33, Authorised, Last updated: 21/11/2019 -
List item
Human medicine European public assessment report (EPAR): Tamiflu (updated)
oseltamivir, Influenza, Human
Date of authorisation: 20/06/2002, Revision: 37, Authorised, Last updated: 20/11/2019 -
List item
Human medicine European public assessment report (EPAR): Rixubis (updated)
nonacog gamma, Hemophilia B
Date of authorisation: 19/12/2014,, Revision: 7, Authorised, Last updated: 20/11/2019
-
List item
Human medicine European public assessment report (EPAR): Keytruda (updated)
Pembrolizumab, Melanoma, Hodgkin Disease, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 17/07/2015,, Revision: 23, Authorised, Last updated: 20/11/2019
-
List item
Human medicine European public assessment report (EPAR): Pelmeg (updated)
pegfilgrastim, Neutropenia
Date of authorisation: 20/11/2018,, , Revision: 2, Authorised, Last updated: 20/11/2019
-
List item
Human medicine European public assessment report (EPAR): Cinacalcet Mylan (updated)
cinacalcet hydrochloride, Hyperparathyroidism, Secondary, Hypercalcemia
Date of authorisation: 19/11/2015,
, Revision: 4, Authorised, Last updated: 20/11/2019
-
List item
Human medicine European public assessment report (EPAR): Mulpleo (previously Lusutrombopag Shionogi) (updated)
Lusutrombopag, Thrombocytopenia
Date of authorisation: 18/02/2019,, Revision: 3, Authorised, Last updated: 20/11/2019
-
List item
Human medicine European public assessment report (EPAR): Lucentis (updated)
ranibizumab, Wet Macular Degeneration, Macular Edema, Myopia, Degenerative, Diabetes Complications
Date of authorisation: 22/01/2007, Revision: 35, Authorised, Last updated: 19/11/2019 -
List item
Human medicine European public assessment report (EPAR): Olanzapine Teva (updated)
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 12/12/2007,, Revision: 26, Authorised, Last updated: 19/11/2019
-
List item
Human medicine European public assessment report (EPAR): Benepali (updated)
etanercept, Arthritis, Psoriatic, Arthritis, Rheumatoid, Psoriasis
Date of authorisation: 13/01/2016,, , Revision: 10, Authorised, Last updated: 19/11/2019
-
List item
Human medicine European public assessment report (EPAR): Invanz (updated)
ertapenem sodium, Community-Acquired Infections, Streptococcal Infections, Staphylococcal Infections, Gram-Negative Bacterial Infections, Surgical Wound Infection, Pneumonia, Bacterial
Date of authorisation: 18/04/2002, Revision: 22, Authorised, Last updated: 19/11/2019 -
List item
Human medicine European public assessment report (EPAR): Defitelio (updated)
defibrotide, Hepatic Veno-Occlusive Disease
Date of authorisation: 18/10/2013,, 
, 
, Revision: 10, Authorised, Last updated: 19/11/2019
-
List item
Human medicine European public assessment report (EPAR): Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva) (updated)
sevelamer carbonate, Hyperphosphatemia, Renal Dialysis
Date of authorisation: 15/01/2015, Revision: 16, Authorised, Last updated: 19/11/2019 -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm (updated)
clopidogrel hydrogen sulphate, Myocardial Infarction, Acute Coronary Syndrome, Peripheral Vascular Diseases, Stroke
Date of authorisation: 18/02/2015,, Revision: 8, Authorised, Last updated: 19/11/2019
-
List item
Human medicine European public assessment report (EPAR): Zirabev (updated)
bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms
Date of authorisation: 14/02/2019,, , Revision: 2, Authorised, Last updated: 18/11/2019
-
List item
Human medicine European public assessment report (EPAR): Onivyde pegylated liposomal (previously known as Onivyde) (updated)
irinotecan hydrochloride trihydrate, Pancreatic Neoplasms
Date of authorisation: 14/10/2016,, Revision: 4, Authorised, Last updated: 18/11/2019
-
List item
Human medicine European public assessment report (EPAR): Matever (updated)
levetiracetam, Epilepsy
Date of authorisation: 03/10/2011,, Revision: 19, Authorised, Last updated: 18/11/2019